 |
 |
thanks ray. this does sound promising. There is also a clinical trials.gov record (with actual phase II data) at http://clinicaltrials.gov/ct2/result...&Search=Search Also a list of other clinical trials for other conditions. It was also being studied as a treatment for Huntington’s. The Parkinson Pipeline Project treatment database was following the progress of GM1 Ganglioside for a number of years. See: http://apexutf.shellprompt.net/pls/a...RN_PAGE:185,12 The latest news was that as of June, 2006, the treatment phase of the study was closed to recruitment. Then 6 years to analyze and publish the data? this was one of the rare successful phase II trials. You’d think there would be some interest in developing it further and faster?linda www.pdpipeline.org ---------- Original Message ---------- From: Rayilyn Brown <[log in to unmask]> To: [log in to unmask] Subject: ganglioside Date: Sun, 13 Jan 2013 11:23:27 -0700 http://www.news-medical.net/news/20121130/GM1-ganglioside-effectively-treats-patients-with-Parkinsons-disease.aspx Ray Rayilyn Brown Past Director AZNPF Arizona Chapter National Parkinson Foundation ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn